Emerging and Practical Concepts and Controversies in Adult and AYA ALL

Focus on Australia

Overview

Aptitude Health organized this webinar on recent developments in the treatment of AYA and adult ALL patients that included information from ASH 2021, ASCO 2022, EHA 2022, EBMT 2022, as well as recent/upcoming peer-reviewed papers.
Experts shared their insights on enactment of new paradigms, including administration of new treatments such as bispecifics and patient monitoring and management. They also discussed strategic implementation of minimal residual disease (MRD) monitoring.

Date and Location

July 18 and September 6, 2022, Virtual Meeting

Meeting Content

View the slides and watch the video of the meeting and Q&A Session on Emerging and Practical Concepts and Controversies in Adult and AYA ALL: Focus on Australia

Co-chairs

Nicola Gokbuget

Nicola Gökbuget, MD

University Hospital Frankfurt, Germany

Nicolas Boissel

Nicolas Boissel, MD, PhD

Hôpital Saint-Louis, France

Agenda

 

Local Chair: Shaun Fleming, MBBS(Hons), FRACP, FRCPA
Co-chairs: Nicola Gökbuget, MD, Nicolas Boissel, MD, PhD

Time Topic Presenter
10 min Welcome, Meeting Overview, and Introductions Shaun Fleming, MBBS(Hons), FRACP, FRCPA
25 min Overview of Key Takeaways in MRD and Its Role in Adult and AYA ALL Treatment Nicola Gökbuget, MD
25 min Overview of Key Takeaways in Recent Developments in AYA/Adult ALL Nicolas Boissel, MD, PhD
75 min Questions to Dr Boissel and Dr Gökbuget Chun Yew Fong, MBBS, BMedSci, FRACP, FRCPA, PhD, and Matt Greenwood, MBBS, FRACP, FRCPA (panelists)
5 min Conclusions and Wrap-up Shaun Fleming, MBBS(Hons), FRACP, FRCPA